{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:44:50Z","timestamp":1795207490651,"version":"4.10.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":142,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1186\/s12968-022-00859-z","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T04:02:48Z","timestamp":1653278568000},"page":"31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0105-935X","authenticated-orcid":false,"given":"Andrea","family":"Ponsiglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Petretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s12968-022-00859-z_bib1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry\u2019s disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1186\/s12968-022-00859-z_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1186\/s12968-022-00859-z_bib3","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.3390\/jcm10184168","article-title":"Review of mechanisms, pharmacological management, psychosocial implications, and holistic treatment of pain in Fabry disease","volume":"10","author":"Rajan","year":"2021","journal-title":"J Clin Med"},{"key":"10.1186\/s12968-022-00859-z_bib4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/cells10061532","article-title":"Fabry cardiomyopathy: current practice and future directions","volume":"10","author":"Yim","year":"2021","journal-title":"Cells"},{"key":"10.1186\/s12968-022-00859-z_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","article-title":"Fabry disease in cardiology practice: Literature review and expert point of view","volume":"112","author":"Hag\u00e8ge","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1186\/s12968-022-00859-z_bib6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13244-021-01067-6","article-title":"Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study","volume":"12","author":"Nappi","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib8","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1148\/radiol.2020200909","article-title":"Predictive value of cardiac MRI in patients with Fabry disease","volume":"296","author":"Tao","year":"2020","journal-title":"Radiology"},{"key":"10.1186\/s12968-022-00859-z_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/s12968-022-00859-z_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.2016141802","article-title":"State of the art: Clinical applications of cardiac T1 mapping","volume":"278","author":"Schelbert","year":"2016","journal-title":"Radiology"},{"key":"10.1186\/s12968-022-00859-z_bib11","first-page":"932","article-title":"Assessment of cardiac involvement in Fabry Disease (FD) with native T1 mapping","volume":"191","author":"Roller","year":"2019","journal-title":"R\u00f6Fo"},{"key":"10.1186\/s12968-022-00859-z_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1186\/s12968-022-00859-z_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/CLEP.S66677","article-title":"Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank","volume":"6","author":"Margulis","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1186\/s12968-022-00859-z_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.21037\/cdt-20-897","article-title":"Quantification of myocardial deformation in patients with Fabry disease by cardiovascular magnetic resonance feature tracking imaging","volume":"11","author":"Zhao","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1186\/s12968-022-00859-z_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10554-020-01823-7","article-title":"Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping","volume":"36","author":"R\u00e9ant","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diii.2019.08.006","article-title":"Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping","volume":"101","author":"Deborde","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2214\/AJR.20.23102","article-title":"Increased spread of native T1 values assessed with MRI as a marker of cardiac involvement in Fabry disease","volume":"216","author":"Karur","year":"2021","journal-title":"Am J Roentgenol"},{"key":"10.1186\/s12968-022-00859-z_bib18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ehjci\/jeaa101","article-title":"The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage","volume":"22","author":"Augusto","year":"2021","journal-title":"Eur Hear J - Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12968-019-0557-0","article-title":"Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy","volume":"21","author":"Mathur","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/s12968-022-00859-z_bib20","doi-asserted-by":"crossref","first-page":"e008424","DOI":"10.1161\/CIRCIMAGING.118.008424","article-title":"Predictors of clinical evolution in prehypertrophic Fabry Disease","volume":"12","author":"Camporeale","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ehjci\/jez039","article-title":"Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group","volume":"20","author":"Imbriaco","year":"2019","journal-title":"Eur Hear J - Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12968-017-0386-y","article-title":"Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects","volume":"19","author":"Liu","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/s12968-022-00859-z_bib23","doi-asserted-by":"crossref","first-page":"e0157565","DOI":"10.1371\/journal.pone.0157565","article-title":"Reduced right ventricular native myocardial T1 in Anderson-Fabry disease: comparison to pulmonary hypertension and healthy controls","volume":"11","author":"Pagano","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1186\/s12968-022-00859-z_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/0284185116675657","article-title":"Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping","volume":"58","author":"Walter","year":"2017","journal-title":"Acta radiol"},{"key":"10.1186\/s12968-022-00859-z_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","article-title":"Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance","volume":"16","author":"Pica","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/s12968-022-00859-z_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 mapping in characterizing myocardial disease: a comprehensive review","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ Res"},{"key":"10.1186\/s12968-022-00859-z_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10554-019-01717-3","article-title":"Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease","volume":"36","author":"Vo","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib30","first-page":"38","article-title":"Cardiac abnormalities in Anderson-Fabry disease and Fabry\u2019s cardiomyopathy","volume":"22","author":"Morrissey","year":"2011","journal-title":"Cardiovasc J Afr"},{"key":"10.1186\/s12968-022-00859-z_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcmg.2015.11.005","article-title":"T1 mapping basic techniques and clinical applications","volume":"9","author":"Taylor","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1532-429X-14-26","article-title":"T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region","volume":"14","author":"Kawel","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/s12968-022-00859-z_bib33","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/jmri.27639","article-title":"Myocardial T1 values at 1.5 T: normal values for General Electric scanners and sex-related differences","volume":"54","author":"Meloni","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1566523218666180404161315","article-title":"Genetics and gene therapy of Anderson-Fabry disease","volume":"18","author":"Simonetta","year":"2018","journal-title":"Curr Gene Ther"},{"key":"10.1186\/s12968-022-00859-z_bib35","doi-asserted-by":"crossref","unstructured":"MacDermot KD, Holmes A, Miners AH. Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis. 2001;24 Suppl 2:13\u20134; discussion 11\u20132.","DOI":"10.1023\/A:1012447102358"},{"key":"10.1186\/s12968-022-00859-z_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1186\/s12968-022-00859-z_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin Genet"},{"key":"10.1186\/s12968-022-00859-z_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.gene.2017.10.064","article-title":"Female Fabry disease patients and X-chromosome inactivation","volume":"641","author":"Juchniewicz","year":"2018","journal-title":"Gene"},{"key":"10.1186\/s12968-022-00859-z_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2017.06.079","article-title":"Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy","volume":"248","author":"Frustaci","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1186\/s12968-022-00859-z_bib40","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","article-title":"Proposed stages of myocardial phenotype development in Fabry disease","volume":"12","author":"Nordin","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1186\/s12968-022-00859-z_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jjcc.2019.09.002","article-title":"Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients","volume":"75","author":"Nojiri","year":"2020","journal-title":"J Cardiol"},{"key":"10.1186\/s12968-022-00859-z_bib42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jelectrocard.2018.03.001","article-title":"Meta-analysis of Tpeak\u2013Tend and Tpeak\u2013Tend \/QT ratio for risk stratification in congenital long QT syndrome","volume":"51","author":"Tse","year":"2018","journal-title":"J Electrocardiol"},{"key":"10.1186\/s12968-022-00859-z_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2019.10.010","article-title":"Pathogenesis of Fabry nephropathy: the pathways leading to fibrosis","volume":"129","author":"Rozenfeld","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"Suppl 2","key":"10.1186\/s12968-022-00859-z_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1012423924648","article-title":"Renal pathological changes in Fabry disease","volume":"24","author":"Sessa","year":"2001","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12968-022-00859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12968-022-00859-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723011730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723011730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12968-022-00859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:17:53Z","timestamp":1769577473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664723011730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1097664723011730"],"URL":"https:\/\/doi.org\/10.1186\/s12968-022-00859-z","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s12968-022-00859-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance","name":"copyright","label":"Copyright"}],"article-number":"31"}}